TEDD at TERMIS European Chapter Meeting 2019.
The theme of this year's TERMIS meeting in Rhodes, Greece was "Tissue Engineering Therapies: From concept to clinical translation and commercialization". The conference is highly crucial to scientists, clinicians and industries interested in tissue engineering and regenerative medicine therapies that aspire to revolutionize healthcare with their reparative capacity. The program of TERMIS EU 2019 included specific workshops and symposia in tissue engineering and regenerative medicine tools, technologies and discoveries; clinical trials; regulatory approval of new devices; scaling up; commercialization; career development of young investigators; women leadership and representation; education; and outreach.
Dr Kopanska represented TEDD at the exhibition booth. Several TEDD member companies presented their products and services as exhibitors. TEDD Chair Prof. Michael Raghunath co-chaired three symposia and gave a presentation. Two of the symposia were TEDD-specific: Industrial Engineering of 3D Tissue Models--Building Physiology for Drug Development and Substance Testing and What Industry Really Wants and Needs.
For more details and impressions, check: https://www.zhaw.ch/de/lsfm/forschung/ chemie-und-biotechnologie/competencecentre-tedd/partnership/past-events/
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||TEDD--Tissue Engineering For Drug Development and Substance Testing|
|Publication:||ALTEX: Alternatives to Animal Experimentation|
|Date:||Jun 22, 2019|
|Previous Article:||TEDD Sino-Swiss Workshop on Tissue Engineering.|
|Next Article:||TEDD at Pint of Science with talk about animal use in science.|